BioSyent Inc. (CVE:RX) Insider FAX Capital Corp. Sells 500,000 Shares

BioSyent Inc. (CVE:RX) insider FAX Capital Corp. sold 500,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of C$10.05, for a total transaction of C$5,025,000.00.

BioSyent Price Performance

Shares of CVE:RX opened at C$10.85 on Friday. The company has a market capitalization of C$125.75 million, a PE ratio of 18.08 and a beta of 0.94. The company has a current ratio of 6.13, a quick ratio of 6.91 and a debt-to-equity ratio of 3.40. BioSyent Inc. has a twelve month low of C$7.66 and a twelve month high of C$11.45. The firm has a 50 day simple moving average of C$10.18 and a 200-day simple moving average of C$9.32.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.